The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta‐analysis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Kearon, C., Ginsberg, J. S., Kovacs, M. J., Anderson, D. R., Wells, P., Julian, J. A., MacKinnon, B., Weitz, J. I., Crowther, M. A., Dolan, S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035422 · Cited by 751
Self-citationBaglin, T., Luddington, R., Brown, K., & Baglin, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14111-6 · Cited by 694
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
Agnelli, G., Prandoni, P., Santamaria, M. G., Bagatella, P., Iorio, A., Bazzan, M., Moia, M., Guazzaloca, G., Bertoldi, A., Tomasi, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450302 · Cited by 591
Rodger, M. A., Kahn, S. R., Wells, P. S., Anderson, D. A., Chagnon, I., Le Gal, G., Solymoss, S., Crowther, M., Perrier, A., White, R., et al. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080493 · Cited by 581
Self-citationIorio, A., Kearon, C., Filippucci, E., Marcucci, M., Macura, A., Pengo, V., Siragusa, S., & Palareti, G. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.367 · Cited by 385
Prandoni, P., Prins, M. H., Lensing, A. W. A., Ghirarduzzi, A., Ageno, W., Imberti, D., Scannapieco, G., Ambrosio, G. B., Pesavento, R., Cuppini, S., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00003 · Cited by 232
Research works printed but not linked: 19
- Kearon, 2008, Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence‐based Clinical Practice Guidelines, Chest, 133, 454, 10.1378/chest.08-0658 · DOI · Paper page
- Linkins, 2003, Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta‐analysis, Ann Intern Med, 139, 893, 10.7326/0003-4819-139-11-200312020-00007 · DOI · Paper page
- Prandoni, 2007, The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients, Haematologica, 92, 199, 10.3324/haematol.10516 · DOI · Paper page
- Prandoni, 2007, Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosis, J Thromb Haemost, 5, 1555, 10.1111/j.1538-7836.2007.02581.x · doi:10.1111/j.1538-7836.2007.02581.x
- Siragusa, 2008, Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study, Blood, 112, 511, 10.1182/blood-2008-01-131656 · DOI · Paper page
- Cosmi, 2010, Residual venous obstruction, alone and in combination with D‐dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study, Eur J Vasc Endovasc Surg, 39, 356, 10.1016/j.ejvs.2009.11.022 · DOI
- Cosmi, 2005, D‐dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis, Thromb Haemost, 94, 969, 10.1160/TH05-02-0095 · DOI
- Prandoni, 2002, Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism, Ann Intern Med, 137, 955, 10.7326/0003-4819-137-12-200212170-00008 · DOI · Paper page
- Young, 2006, Post‐treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality, J Thromb Haemost, 4, 1919, 10.1111/j.1538-7836.2006.02120.x · DOI
- Higgins, 2009, Cochrane handbook for systematic reviews of interventions version 5.0.2, Cochrane Database Syst Rev
- Higgins, 2002, Quantifying heterogeneity in a meta‐analysis, Stat Med, 21, 1539, 10.1002/sim.1186 · DOI · Paper page
- Piovella, 2002, Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis, Haematologica, 87, 515
- Cosmi, 2005, The role of D‐dimer and residual venous obstruction in recurrence of venous thromboembolism after anticoagulation withdrawal in cancer patients, Haematologica, 90, 713
- Poli, 2008, Combination of D‐dimer, F1 + 2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal, J Thromb Haemost, 6, 708, 10.1111/j.1538-7836.2008.02900.x · DOI
- Kim, 2009, Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea, Thromb Res, 123, 436, 10.1016/j.thromres.2008.05.009 · DOI
- Kearon, 1999, A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism, N Engl J Med, 340, 901, 10.1056/NEJM199903253401201 · DOI · Paper page
- Kearon, 2004, A comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor, J Thromb Haemost, 2, 743, 10.1046/j.1538-7836.2004.00698.x · DOI
- Siragusa, 2010, The optimal duration of anticoagulant therapy in patients with cancer‐related deep vein thrombosis: the advantage of using residual vein thrombosis (the Cancer‐DACUS study), Blood, 116, 10.1182/blood.V116.21.190.190 · doi:10.1182/blood.v116.21.190.190
- Linkins, 2006, Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis, Thromb Res, 117, 241, 10.1016/j.thromres.2005.02.011 · DOI
Cited by
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
Self-citationOrtel, T. L., Neumann, I., Ageno, W., Beyth, R., Clark, N. P., Cuker, A., Hutten, B. A., Jaff, M. R., Manja, V., Schulman, S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001830 · Cited by 1,489
O’Donnell, T. F., Passman, M. A., Marston, W. A., Ennis, W. J., Dalsing, M., Kistner, R. L., Lurie, F., Henke, P. K., Gloviczki, M. L., Eklöf, B. G., et al. (2014) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.04.049 · Cited by 720
Rodger, M. A., Le Gal, G., Anderson, D. R., Schmidt, J., Pernod, G., Kahn, S. R., Righini, M., Mismetti, P., Kearon, C., Meyer, G., et al. (2017) · BMJ · doi:10.1136/bmj.j1065 · Cited by 238
Self-citation
Metadata
- Authors
- CARRIER, M., RODGER, M. A., WELLS, P. S., RIGHINI, M., & LE GAL, G.
- Venue
- Journal of Thrombosis and Haemostasis
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 9
- Issue
- 6
- Pages
- 1119-1125
- ISSN
- 1538-7836 (ISSN-L)
- OpenAlex
- W1924958570
- Cited by
- 159
- References
- 7
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4205 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1111/j.1538-7836.2011.04254.x
- The paper
- CARRIER, M., RODGER, M. A., WELLS, P. S., RIGHINI, M., & LE GAL, G. (2011). Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta‐analysis. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/j.1538-7836.2011.04254.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.